SS Innovations International, Inc. (SSII) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. SS Innovations International, Inc. is a commercial-stage surgical robotics company focused on the "SSI Mantra" system. The company operates primarily in India with a presence in the US. As of June 30, 2024, the company had an installed base of 40 systems globally, with over 1,464 procedures performed in India.
Critical Disclosure: This filing is unaudited and was filed without the required auditor review due to the dismissal of the previous auditor (BF Borgers CPA PC) by the SEC and the ongoing reaudit by the new auditor (BDO India LLP). The company has indicated that prior financial statements (2022-2023) may require restatement.
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | Value (USD) |
|---|---|
| Total Revenue | $11,617,011 |
| Gross Profit | $4,117,163 |
| Gross Margin | 35.4% |
| Net Loss | $(5,579,695) |
| Net Loss Per Share (Basic/Diluted) | $(0.03) |
| Cash and Cash Equivalents | $1,454,675 |
| Restricted Cash | $5,946,502 |
| Total Assets | $38,317,405 |
| Total Liabilities | $21,334,483 |
| Stockholders' Equity | $16,982,922 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased significantly from $3.09 million in the six months ended June 30, 2023, to $11.62 million in the same period in 2024. This was driven by the sale of 17 surgical robotic systems (including one export to Nepal).
- Expense Increase: Selling, General, and Administrative (SG&A) expenses rose from $3.40 million to $9.10 million year-over-year. This increase is attributed to expanded manpower, marketing efforts, and stock-based compensation ($3.25 million).
- Net Loss Expansion: Net loss widened from $2.84 million to $5.58 million, primarily due to the sharp rise in operating expenses outpacing revenue growth.
- Debt and Liquidity: The company raised $4.45 million in short-term debt (convertible and non-convertible promissory notes) during the period. Bank overdraft facilities increased to $7.71 million.
Guidance, Outlook, and Risks
- Going Concern: Management states the financial statements are prepared on a going concern basis but notes that the company relies on debt and equity capital to fund operations. There is no assurance that additional funding will be secured, which could raise substantial doubt about the company's ability to continue as a going concern.
- Regulatory Outlook: The company has initiated regulatory approval processes in the US and EU, with market approvals anticipated in the second half of 2025.
- Accounting Restatement Risk: The filing explicitly states that prior audited financial statements (2022-2023) and interim reports may need to be restated following an internal review and reaudit. No amendments have been filed yet.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of June 30, 2024, citing a lack of written documentation for internal controls and incomplete segregation of duties.
Investor Verification Checklist
- Auditor Status: Verify the completion status of the reaudit by BDO India LLP and the timeline for filing amended 10-K and 10-Q reports.
- Restatement Impact: Monitor for specific details on the magnitude of adjustments required for prior periods once the reaudit is finalized.
- Debt Maturity: Review the terms of the $4.45 million in promissory notes issued in early 2024, which mature in early 2025, and assess refinancing risks.
- Revenue Recognition: Scrutinize the application of ASC 606 regarding deferred revenue and the classification of warranty sales, as noted in the significant accounting policies.
- Related Party Transactions: Confirm the terms and necessity of the $2.45 million in convertible notes and $2.0 million in promissory notes issued to affiliates of the CEO/Chairman.